Home > Healthcare > Medical Devices > Implantable Devices > Spinal Fusion Device Market

Spinal Fusion Device Market Size - By Product Type (Thoracolumbar Devices, Cervical Fixation Devices, Interbody Fusion Devices), Disease Type (Degenerative Disc, Trauma & Fractures), Surgery, Material Type, End-use & Global Forecast, 2024 – 2032

  • Report ID: GMI8294
  • Published Date: Feb 2024
  • Report Format: PDF

Spinal Fusion Device Market Size

Spinal Fusion Device Market was valued at around USD 8.4 billion in 2023 and is expected to register around 4.6% CAGR from 2024 to 2032, driven by key factors such as the increasing incidence of spinal diseases, alongside a rise in number of trauma and injury cases.

Spinal Fusion Device Market

The incidence of spinal diseases, particularly spinal cord injury (SCI) and spinal disorders, is expected to be the primary driver of market growth. Factors such as an aging population, sedentary lifestyle, obesity, and traumatic injuries collectively contribute to the increasing burden of spinal diseases worldwide. Moreover, low back pain, a prevalent spinal disorder, affects a significant portion of the population and stands as the leading cause of disability in the U.S. Consequently, due to these factors, the market for spinal fusion devices is expected to experience exponential growth.

Spinal Fusion Device Market Trends

The spinal fusion device industry has witnessed significant technological advancements in recent years, with notable examples including the adoption of healthcare 3D printing and nanotechnology applications. These technologies are driving innovation in device design and manufacturing, emerging as primary trends shaping the market's trajectory.

  • The latest technological advancement in spinal fusion devices involves the utilization of 3D printing technology. This innovation enables the development of customized spinal implants that perfectly tailors to the patient's anatomy, leading to enhanced surgical outcomes. For instance, Orthofix Medical recently introduced a new 3D printed lumbar device designed for posterior lumbar interbody fusion (PLIF) surgeries. This device incorporates a complex 3D printed geometry and a porous surface, facilitating optimal integration with the surrounding bone. Such advancements highlight the transformative potential of 3D printing in the field of spinal fusion devices, offering tailored solutions for individual patients and driving increased demand for these innovative technologies.
  • Additionally, ongoing research is focused on optimizing spinal fusion devices through the application of nanotechnology. For example, efforts are underway to develop nanocoatings for spinal implants, aimed at reducing wear debris generation and enhancing bone ingrowth by modifying surface properties. Moreover, researchers have created a nanocomposite material comprising polymer scaffolds embedded with silver nanoparticles, demonstrating promising results in preventing bacterial colonization and biofilm formation on spinal implants. These innovative technologies represent the forefront of advancements in spinal fusion devices, poised to elevate their popularity and drive increased demand.

Spinal Fusion Device Market Analysis

Global Spinal Fusion Device Market, By Product Type, 2021 - 2032 (USD Billion)

Based on product type, the thoracolumbar devices segment held leading revenue share in 2023 and is likely to cross USD 6.9 billion by 2032.

  • The surgical indications for thoracolumbar spinal fusion procedures are broader than the other fusion procedures. Conditions such as degenerative disc disease, spinal stenosis, spondylolisthesis, and spinal deformities like scoliosis and kyphosis are commonly treated with thoracolumbar fusion, expecting to increase the demand for these devices.  
  • Additionally, modern lifestyles characterized by increased sedentary behavior and higher prevalence of obesity contribute to the development of spinal conditions, further fueling the demand for thoracolumbar spinal fusion procedures to address these issues.

Based on disease type, the degenerative disc segment acquired major revenue share and was valued at around USD 4 billion in 2023.

  • Degenerative disc disease is more prevalent in older individuals, and with the global population aging, there is an increasing number of people at risk of developing this condition. The growing aging population may contribute to the segmental growth.
  • Additionally, smoking, poor nutrition, and lack of regular exercise also contribute to the development and progression of degenerative disc disease. Addressing these lifestyle factors through education and interventions may help mitigate the risk of degenerative disc disease but also increase awareness and demand for treatment options when the disease does occur.
  • Moreover, improved awareness of degenerative disc disease among both patients and healthcare providers, along with advancements in diagnostic imaging technology, has led to earlier detection and diagnosis of the condition. As more individuals are diagnosed with degenerative disc disease, the demand for treatment options, including spinal fusion devices anticipates increasing.

Based on surgery, the minimally invasive spine surgery segment is set to reach around USD 8.5 billion by 2032.

  • Minimally invasive techniques utilize smaller incisions and specialized instruments, resulting in less disruption to surrounding tissues, muscles, and nerves compared to traditional open surgery. Reduced tissue trauma leads to less postoperative pain, faster recovery times, and shorter hospital stays, driving patient demand for minimally invasive approaches, ultimately leads to spinal fusion device market growth.
  • Additionally, minimally invasive techniques aim to preserve as much of the natural spinal anatomy and function as possible. By minimizing disruption to surrounding tissues and structures, these procedures can help maintain spinal stability and mobility, which is particularly important for younger patients or those with active lifestyles. These advantages attracting the patients and health professionals resulting in their increasing demand and market growth. 

Based on material type, the metallic devices accounted for over USD 7.2 billion in 2023.

  • Metallic implants, such as those made from titanium or stainless steel, are known for their excellent biocompatibility, making them suitable for long-term implantation within the body. They are often preferred for their strength and stability, particularly in cases where significant support or fixation is required, such as in complex spinal deformity corrections. Their inherent strengths and stability not only fulfill critical support and fixation needs but also offer a cost-effective solution. Given these advantageous attributes, the demand for metallic implants is projected to escalate, driving substantial growth within this segment.
  • Additionally, metallic implants are compatible with various surgical techniques and adjunctive technologies commonly used in spinal fusion procedures, such as pedicle screw systems, interbody cages, and bone graft materials. Their compatibility with existing instrumentation and surgical approaches makes metallic implants a preferred choice for many surgeons and healthcare facilities.


Global Spinal Fusion Device Market, By End-use (2023)

The spinal fusion device market by end-use is categorized into hospitals, specialty clinics, and other end users. The hospitals segment dominates the market with a revenue of around USD 4.7 billion in 2023.

  • Hospitals serve as essential hubs for spinal fusion procedures, offering specialized equipment, dedicated operating rooms, and a skilled medical workforce to ensure safe and effective surgeries. This robust infrastructure provided by hospitals plays a pivotal role in propelling the market growth.
  • Moreover, hospitals play a critical role in securing reimbursement and insurance coverage for spinal fusion surgeries, as well as related medical expenses. Working with payers and insurance providers, hospitals help facilitate access to spinal fusion procedures for eligible patients, contributing to the overall demand for spinal fusion devices.


North America Spinal Fusion Device Market, 2020 - 2032 (USD Billion)

North America spinal fusion device market accounted for USD 4.4 billion revenue in 2023 and is predicted to witness substantial market growth.

  • North America has a significant proportion of elderly individuals, who are more prone to degenerative spinal conditions such as degenerative disc disease, spinal stenosis, and osteoarthritis. As the population ages, the prevalence of these conditions increases, driving the demand for spinal fusion procedures and devices to address them.
  • Furthermore, North America has a high prevalence of motor vehicle accidents as well as sports injuries, which are a leading cause of traumatic spine injuries. These accidents can result in fractures, dislocations, and other traumatic injuries to the spine, often necessitating surgical intervention and the use of spinal fusion devices to stabilize the spine and promote healing.

Spinal Fusion Device Market Share

The spinal fusion device industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced product based on different technologies is among a key market strategy. Some of the leading industry players including Alphatec Holdings, Inc, B. Braun Melsungen AG, Medtronic Plc, SeaSpine Holding Corporation, Stryker Corporation, and Globus Medical Inc. among others have a notable presence in the market.

Spinal Fusion Device Market Companies

Some of the eminent players participants operating in the spinal fusion device industry include:

  • Alphatec Holdings, Inc.
  • B. Braun Melsungen AG
  • ChoiceSpine LLC
  • Globus Medical Inc.
  • Johnson& Johnson (Depuy Synthes)
  • Medtronic plc
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • SeaSpine Holdings Corporation
  • Stryker Corporation
  • ZimVie Inc.

Spinal Fusion Device Industry News

  • In October 2023, Alphatec Holdings, Inc. introduced the Calibrate LTX lateral expandable implant system, a technological advancement designed to enhance alignment goals with precise lordosis control and disc height restoration in lateral surgery. This launch is expected to enhance the company’s reputation and improve its positioning in the spinal fusion device market.
  • In September 2023, ChoiceSpine LLC received FDA clearance to market the Blackhawk Ti 3D Printed Cervical Spacer System with standalone indication. The Blackhawk Ti system provides intra and post-operative results for patients requiring the anterior cervical approach, offering a wide variety of implant footprints and profiles for disc height restoration and optimal sagittal balancing. This launch may enable the increased customer base to the company and enhance market presence.

This spinal fusion device market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

  • Thoracolumbar devices
    • Anterior lumbar plates
    • Pedicle screw and rods
    • Other thoracolumbar devices
  • Cervical fixation devices
    • Anterior cervical plates
    • Hook fixation systems
    • Other cervical devices
  • Interbody fusion devices

Market, By Disease Type

  • Degenerative disc
  • Complex deformity
  • Trauma & fractures

Market, By Surgery

  • Open spine surgery
  • Minimally invasive spine surgery

Market, By Material Type

  • Metallic devices
  • Non-metallic devices

Market, By End-use

  • Hospitals
  • Specialty clinics
  • Other end-users

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of Middle East and Africa


Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of spinal fusion device was reached USD 8.4 billion in 2023 and is expected to reach around USD 12.9 billion by 2032, driven by increasing incidence of spinal diseases.

The degenerative disc segment was valued at around USD 4 billion in 2023 and is set to gain traction by 2032, driven by an ageing population who are more susceptible to this disease, and the demand for treatment options.

North America spinal fusion device market accounted for over USD 4.4 billion in 2023 and is predicted to witness substantial growth over 2024 and 2032, driven by a significant proportion of elderly individuals, along with a high prevalence of motor vehicle accidents as well as sports injuries.

Alphatec Holdings, Inc., B. Braun Melsungen AG, ChoiceSpine LLC, Globus Medical Inc., Johnson& Johnson (Depuy Synthes), Medtronic plc, NuVasive, Inc., Orthofix Medical Inc., and SeaSpine Holdings Corporation are some of the major industry contenders.

Spinal Fusion Device Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 406
  • Countries covered: 22
  • Pages: 230
 Download Free Sample